WealthStone’s Hologic HOLX Stock Holding History

WealthStone’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-11	Closed	-$528	–	294
2019 Q2	$528	Buy	+11	New	+$509	﹤0.01%	860

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WealthStone's HOLX Position: Q3 2019 in Review

WealthStone sold out of Hologic (HOLX) in Q3 2019, closing a stake of 11 shares — an estimated $528 sold.

WealthStone first reported a position in HOLX in Q2 2019 and held it in 1 quarter. The position peaked at $528 in Q2 2019. 492 funds tracked by Wall St. Rank hold HOLX as of Q3 2019.

WealthStone reported no remaining Hologic position as of Q3 2019 after selling out during the quarter.
WealthStone sold 11 Hologic shares in Q3 2019, an estimated $528.
WealthStone first reported a position in Hologic in Q2 2019 and held it in 1 quarter.
WealthStone's Hologic position peaked at $528 in Q2 2019.
492 funds tracked by Wall St. Rank held Hologic as of Q3 2019.

Based on WealthStone's 13F filing for Q3 2019, filed 15 Nov 2019.